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Abstract
Polycystic ovary syndrome (PCOS) is a hormonal disorder of women that not only is the leading cause of infertility but also
shows a reciprocal link with oral health. This study aimed to investigate the hypothesis that the levels of putative
periodontal pathogens in saliva and their antibody response in serum are elevated in PCOS, compared to systemic health. A
total of 125 women were included in four groups; 45 women with PCOS and healthy periodontium, 35 women with PCOS
and gingivitis, 25 systemically and periodontally healthy women, 20 systemically healthy women with gingivitis. Salivary
levels of seven putative periodontal pathogens were analyzed by quantitative real-time polymerase chain reaction and
serum antibody levels were analyzed by ELISA. In women with PCOS, salivary Porphyromonas gingivalis, Fusobacterium
nucleatum, Streptococcus oralis and Tannerella forsythia levels were higher than matched systemically healthy women,
particularly in the case of gingivitis. Aggregatibacter actinomycetemcomitans and Treponema denticola levels were similar
among study groups. The presence of PCOS also enhanced P. gingivalis, Prevotella intermedia and S. oralis serum antibody
levels, when gingivitis was also present. Gingival inflammation correlated positively with levels of the studied taxa in saliva,
particularly in PCOS. The presence of P. gingivalis and F. nucleatum in saliva also exhibited a strong positive correlation with
the corresponding serum antibody levels. In conclusion, as an underlying systemic endocrine condition, PCOS may
quantitatively affect the composition of oral microbiota and the raised systemic response to selective members of this
microbial community, exerting a confounding role in resultant gingival inflammation and periodontal health. The most
consistent effect appeared to be exerted on P. gingivalis.
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Introduction
Polycystic ovary syndrome (PCOS) is the most common
endocrine disorder, affecting women of reproductive age with
the prevalence ranging from 6.5% to 8% according to the
National Institutes of Health (NIH) criteria [1]. PCOS is
considered to be a metabolic syndrome with cardiovascular [2],
insulin-dependent diabetes, dyslipidemia and endothelial dysfunc-
tion [3] and visceral obesity [4] risk factors. PCOS is characterised
by chronic low-grade inflammation [5] and it is likely to be
responsible for metabolic abnormalities. Recently, it was reported
that certain pro-inflammatory cytokines, such as interleukin-6 (IL-
6), interleukin-17 (IL-17), tumor necrosis factor-a (TNF-a) were
elevated in women with PCOS, compared to systemically healthy
individuals [6,7]. Prolonged low-grade inflammatory state can be
caused by chronic infections such as gingivitis, which is a common
pathology seen in patients with PCOS [8]. The primary etiological
factor for periodontal diseases is microorganisms in the dental
plaque, such as Porphyromonas gingivalis, Treponema denticola,
Tannerella forsythia, Aggregatibacter actinomycetemcomitans and
Prevotella intermedia species, which can also be detected in saliva
[9]. Importantly, the effect of female steroid hormones on the
composition of oral microbiota has been reported in puberty,
menstruation, pregnancy and with oral contraceptive usage [10].
Nevertheless, there is still limited information about the compo-
sition of oral microbiota, with regards to systemic inflammatory
conditions triggered by hormonal disorders, such as PCOS.
Taking into consideration that periodontal diseases are chronic
infections that cause a low-grade chronic systemic inflammation
[11] it is plausible to consider an association with hormonal
disorders, such as PCOS.
The oral microbiota may trigger systemic antibody responses in
patients with periodontal disease [12,13,14]. It was previously
shown that patients with chronic or aggressive periodontitis have
higher serum anti-bacterial IgG antibodies compared to peri-
odontally healthy individuals with no clinical signs of early-onset
periodontitis [15,16]. However, serum antibody responses to
periodontal pathogens neither confer immunity against periodon-
tal disease [17], nor are they considered as an auxiliary measure
for the diagnosis of this disease [18]. To the contrary there is
evidence that the severity of periodontal disease may negatively
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correlate with local and systemic antibody titers to periodontal
pathogens, such as P. gingivalis and A. actinomycetemcomitans
[19]. The carriage of these two species alone may be a
determinant for their systemic antibody response, but not for the
periodontal health status [16]. On the other hand, the clinical
definition of the periodontitis may be a crucial factor that can
modify the association between P. gingivalis serum antibody titers
and the disease [20]. Because conspicuous differences exist in
antibody titers to periodontal pathogens between periodontal
health and disease, even after successful periodontal therapy, the
systemic antibody responses may mark the history of past
periodontal infection [21]. It needs to be further investigated if
underlying systemic conditions can modify the serum antibody
responses to periodontal pathogens, as well as their relationship is
to periodontal inflammation.
To date, the relationship between oral microbiota, gingival
inflammation and systemic antibody response in presence of
PCOS has not been investigated. The hypothesis of this study is
that salivary levels of putative periodontal pathogens, as well as the
serum antibody levels to them are elevated in patients with PCOS,
particularly in the presence of gingival inflammation. Therefore,
the aim of the study was to investigate the levels of seven oral taxa,
including P. gingivalis, T. denticola, T. forsythia, A. actinomyce-
temcomitans, P. intermedia, F. nucleatum and S. oralis, and the
associated serum antibody responses in women with PCOS,
particularly in presence of gingivitis.
Materials and Methods
Study population and clinical examination
Forty-five women with PCOS and healthy periodontium, 35
women with PCOS and gingivitis, 25 systemically and periodon-
tally healthy women, and 20 systemically healthy women with
gingivitis were recruited in this study from the outpatient clinic of
Department of Endocrinology, School of Medicine, Aydın
Government Hospital, Turkey, between October 2012 and April
2013. The study was conducted in full accordance with ethical
principles, including the World Medical Association’s Declaration
of Helsinki, as revised in 2008 and was approved by the Ethics
Committee of the Ege University with the protocol number 13-
5.1/13. The study protocol was explained and written informed
consent was received from each individual prior to enrolment. The
study conforms to STROBE guidelines for observational studies
[22]. Complete medical and dental histories were obtained from
each individual. Inclusion to the PCOS group was based on the
criteria by Rotterdam with the presence of at least two of the
following: polycystic ovaries, oligomenorrhea and/or anovulation,
hyperandrogenism (clinical and/or biochemical) [23]. Inclusion
criteria for the systemically healthy group were; history of regular
menstrual cycles, no clinical or biochemical sign of hyperandro-
genism, matching with the PCOS group in body mass index (BMI)
and exclusion of PCOS by ultrasound examination. Systemic
exclusion criteria were hyperandrogenism (tested by levels of 17-a-
hydroxyprogesterone), diabetes mellitus, hyperprolactemia, con-
genital adrenal hyperplasia, thyroid disorders, Cushing’s syn-
drome, hypertension, hepatic or renal dysfunction, BMI.30 kg/
m2, and cardiovascular diseases. None of the patients had been
using medications such as oral contraceptive agents, steroid
hormones, insulin-sensitizing drugs and antibiotics or anti-
inflammatory drugs that could affect their periodontal status
within the last 6 months before inclusion in the study. Upon
confirmation of eligibility for enrolment in the study, all
individuals returned to the clinic for clinical periodontal measure-
ments including probing depth (PD), plaque index (PI) [24], and
bleeding on probing (BOP; +/2). Clinical periodontal measure-
ments were performed at 6 sites on each tooth (mesio-buccal, mid-
buccal, disto-buccal, mesio-lingual, mid-lingual and disto-lingual
locations), except for third molars, using a Williams periodontal
probe (Hu-Friedy, Chicago, IL). BOP was deemed positive if it
occurred within 15 seconds after application of the probe. The
clinical periodontal measurements were performed by a single
calibrated examiner (Aliye Akcalı).
Patient selection was based on clinical and radiographic criteria
proposed by the 1999 International World Workshop for a
Classification of Periodontal Disease and Conditions [25].
Diagnosis of gingivitis was assigned when BOP scores .50% of
all sites, PD ,3 mm at 90% of the measured sites and no more
than one site had a PD .4 mm or clinical attachment level (CAL)
#1 mm, and no clinical and/or radiographic sign of periodontitis
was evident.
Collection and processing of saliva and serum
All salivary samples were collected in the morning between 8:00
am and 9:00 am. Participants were asked to avoid oral hygiene
measures (flossing, brushing and mouth-rinses), eating, and
drinking for 2 h before collection. For saliva collection, the
individuals were asked to rinse their mouth with distilled water for
2 min and wait for 10 min after rinsing before expectorating
whole saliva into sterile 50 ml tubes for 5 min. The collected saliva
samples were then placed on ice, supplemented with EDTA-free
Protease Inhibitor Cocktail (Roche Applied Science, Switzerland)
prior to centrifuging at 100006g for 15 min at 4uC. The resulting
supernatants were then immediately aliquoted and frozen at 2
80uC for future use, whereas the resulting pellet was re-suspended
in 500 ml of phosphate-buffered saline (PBS), and used for DNA
extraction, as described further.
For serum collection, a total of 5 ml of venous blood were taken
into BD Vacutainer blood collection tubes with silicone-coated
interior (BD Diagnostics, Franklin Lakes, NJ, USA) by a standard
venipuncture method. The collected serum samples were left at
room temperature to allow for blood clotting and then centrifuged
at 15006g for 15 min at 4uC to remove the fibrin clot and cellular
elements. All serum samples were then immediately aliquoted and
frozen at 280uC.
Bacterial quantification by quantitative real-time
Polymerase Chain Reaction (qPCR)
For determining microbiological composition of saliva, qPCR
was employed in order to define the presence and levels of seven
different oral taxa in the salivary samples. A volume of 300 ml of
the re-suspended pellet (described above) was used for DNA
extraction using the GenElute bacterial genomic DNA kit (Sigma
Aldrich, Buch, Switzerland) according to the manufacturer’s
guidelines for the Gram positive lysis protocol, with the following
modifications. Mutanolysin (Sigma Aldrich, Buchs, Switzerland)
was added for the extraction of streptococcal DNA from the
samples. The lysis steps were expanded from 30 min to 1 h
(lysozyme/mutanolysin step), and from 10 min to 30 min (pro-
teinase K step), respectively. The recommended RNase A
treatment step for 2 min was also performed, in-between the
two lysis steps.
Following extraction, the DNA concentration was determined
using a NanoDrop ND-1000 (Thermo-Fisher Scientific, Wohlen,
Switzerland). All species-specific primers for P. gingivalis, T.
denticola, T. forsythia, A. actinomycetemcomitans, P. intermedia, F.
nucleatum and S. oralis used in the qPCR reaction were described
recently [26,27]. For determination of total bacterial counts,
universal primers were used as described elsewhere [28]. DNA
Polycystic Ovary Syndrome and Oral Microbiota
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concentration was diluted to 20 ng/reaction. The qPCR reaction
was run in a total volume of 15 ml, containing 7.5 ml of 2x SYBR
Green PCR Master Mix (Life Technologies, Zug, Switzerland),
6 ml of DNA template and 1.5 ml of primer pair solution (1 mM/
reaction). Amplification of the extracted DNA template was
performed in a real time PCR system (Step One Plus, Applied
Biosystems, Life Technologies, Basel, Switzerland by a initial
incubation of 10 min at 95uC, followed by 40 cycles of 15 s at
95uC and 1 min at 60uC). From the obtained Cq values, number
of copies/reaction was calculated for each sample according to the
standard curve values obtained from the amplification of known
DNA amounts extracted from pure culture isolates of each
bacterial taxa (lowest amount: 0.0001 ng/reaction). The theoret-
ical bacterial numbers in each sample were calculated as total
bacterial DNA counts based on the measured amount of DNA and
the estimated genome weight [26,27].
Immunological response assessment by enzyme-linked
immunosorbant assay (ELISA)
For determining the systemic antibody responses to oral
microbiota, ELISA was employed in order to define presence
and levels of the antibody levels of the designated seven different
oral taxa, in 124 serum samples (PCOS with healthy periodon-
tium, n= 45; PCOS with gingivitis, n = 35; systemically and
periodontally healthy, n= 24; systemically healthy with gingivitis,
n = 20). The following strains were used as bacterial antigens: P.
gingivalis ATCC 33277T (OMZ 308), T. denticola ATCC 35405
(OMZ 661), T. forsythia (OMZ 1047), A. actinomycetemcomitans
ATCC 33384 (OMZ 295), P. intermedia (OMZ 278), F.
nucleatum (OMZ 598), and S. oralis (OMZ 607). Once the
bacterial cultures were grown, then the broth was removed by
centrifugation at 40006g, the bacterial cell pellets were washed
three times with PBS. The density of bacterial suspension was
adjusted to an optical density of OD550 nm 0.10 in PBS with 0.02%
sodium azide. For antigen coating, the ELISA microplates were
incubated with 200 ml of each bacterial culture and fixed with
0.1% glutaraldehyde solution at room temperature for 45 min.
Afterwards, the unspecific binding was blocked by 1% bovine
serum albumin (BSA) for 2 h at 37uC in borate buffer saline (BBS)
(137 mM H3BO3, 25 mM Na2B4O7, 75 mM NaCl, pH=8), and
then the wells were washed twice with BBS.
The reference serum with relatively high titer was selected as
described earlier [29]. Two-fold serial dilutions were made with
use of the BBS buffer. The serially diluted reference serum samples
as well as the diluted test serum samples (predetermined optimal
dilutions for each bacteria were 1:100 for all other species except
for T. denticola which was 1:10) were added to each well, and
incubated for 1 h at 37uC. Additionally, the last two wells were
blank (without any samples) and served as negative controls. Each
well was washed five times with BBS, and incubated with 100 ml of
horseradish peroxidase (HRP)-conjugated goat anti- human IgG
(H+L) antibodies at 1:5000 dilution (GAHu/IgG(Fc)/PO, 6.3 mg/
ml, Nordic Immunological Laboratories, Netherlands) for 2 h at
37uC. Thereafter, colour development was performed with 100 ml
of substrate buffer for 15 min at room temperature, and stopped
by addition of 50 ml of 2.5 M H2SO4. The absorbance was
measured spectrophotometrically at 492 nm using a microplate
reader (Epoch, BioTek, Luzern, Switzerland). The reciprocal
relation between the reference serum dilution (assigned as
arbitrary ELISA unit; EU) and OD492 measurement was
approximated by a 4-parameter polynomial curve. Highest mean
absorbance of the reference serum (1:400 dilution) was assigned to
100 ELISA Units (EU). The arbitrary units of the test samples
were then determined by comparing the absorbance of the
samples to the standard curve.
Statistical analysis
The distribution of the data was evaluated by D’Agostino-
Pearson omnibus normality test. Comparisons between all groups
for non-normally distributed variables (bacterial counts and
antibody levels) were performed by the Kruskal-Wallis test and
Dunn’s test was used in order to correct for multiple comparisons.
For normally distributed variables (age, PI, BOP and PD) ordinary
two-way ANOVA test with Holm-Sidak’s multiple comparison test
(family-wise significance and confidence level 0.05) was used.
Correlations between BOP, PI scores, PD levels, numeric levels of
detection of different taxa in saliva and antibody levels of different
taxa in serum according to systemic health status, were analysed
by Spearman’s correlation test. For this, in order to control the
false discovery rate in multiple testing, Benjamini and Hochberg
method was applied. The Statistical analyses were conducted using
the statistical software (GraphPad Prism version 6.00c for Mac OS
X, GraphPad Software, La Jolla California USA), and statistical
significance was considered at p,0.05.
Results
Clinical findings
Demographics and full mouth clinical findings are provided in
Table 1. Mean PD and CAL were below 3 mm in all the study
groups, whereas PI, BOP and PD scores were significantly higher
in the gingivitis groups, either systemically healthy or with PCOS.
Clinical periodontal parameters were similar in the gingivitis
groups with or without PCOS.
Analysis of bacterial counts in saliva
The microbiological composition of saliva was evaluated using
qPCR either for total bacterial counts, or for each one of the seven
individual species. Their frequency of detection was also calculated
(Table 2). Total bacterial counts were statistically similar between
the four study groups (Figure 1A). Among the specific species, no
differences were found in the numbers of A. actinomycetemcomi-
tans (Figure 1B) and T. denticola (Figure 1C) between clinical
groups. The levels of P. gingivalis (Figure 1D) and F. nucleatum
(Figure 1E) were also found to be similar in systemically healthy
women, irrespective of the presence of gingivitis. In contrast, these
were significantly higher in women with PCOS and gingivitis, than
any of the other three groups. Accordingly, P. intermedia levels
were also significantly higher in women with PCOS and gingivitis,
compared to systemically or periodontally healthy women, but
there was no difference between the two gingivitis groups
(Figure 1F). T. forsythia levels were higher in women with PCOS
and gingivitis compared to periodontal health, but there were no
differences between any of the other clinical group comparisons
(Figure 1G). S. oralis was significantly higher in women with
PCOS and gingivitis, than systemically or periodontally healthy
women (Figure 1H).
Analysis of bacterial antibody levels in serum
Serum antibody responses to the selected oral species were
further investigated. No pronounced differences were found
between clinical groups. A statistically significant difference was
observed in the case of antibody responses to P. gingivalis, but
only between women with PCOS and gingivitis, compared to
systemically and periodontally healthy women (Figure 2A). No
differences between any of the clinical groups were found for T.
denticola (Figure 2B), T. forsythia (Figure 2C), A. actinomycetem-
Polycystic Ovary Syndrome and Oral Microbiota
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comitans (Figure 2D) and F. nucleatum (Figure 2E). Another
observation was that P. intermedia and S. oralis antibody levels
were significantly higher in the periodontally healthy women with
PCOS, compared to the systemically healthy women with
gingivitis (Figure 2F and 2G, respectively).
Correlation analyses between clinical, microbiological
and serological parameters
The Spearman’s rank correlation analysis was used to
investigate the correlation between clinical parameters, levels of
detection of different species in saliva (Table 3) and antibody levels
in serum (Table 4) according to the systemic health status (PCOS
or systemically healthy). Following the calculation of exact p
values, Benjamini and Hochberg method was applied to identify
the corrected significance level, and values below the threshold
level were accepted statistically significant. In the systemically
healthy group, a significant positive correlation was indicated
between BOP and levels of P. intermedia, T. forsythia and T.
denticola in saliva, while P. gingivalis, which was at the border of
being significant (p=0.051). In case of the PCOS group, the
correlations between BOP and all seven different species were
significant. Importantly, all these correlations proved to be
stronger within the PCOS group, rather than the systemically
healthy group (Table 3).
In terms of serum antibody responses, a significantly negative
correlation was found between BOP and T. forsythia or S. oralis in
the systemically healthy group (Table 4). When the association
between bacterial salivary levels and their serum antibody levels
were investigated, a significant positive correlation was found in
the cases of P. gingivalis and F. nucleatum (Table 5).
Discussion
The incidence and clinical presentation of plaque-induced
gingivitis are affected by increased sex steroid hormone levels [10].
Puberty has a transient effect on the inflammatory status of the
gingiva, but the severity or the time of onset of gingival
inflammation varies in different studies [30]. Severity of gingivitis
during the pregnancy can be increased independently from dental
plaque accumulation [31]. A quantitative shift in the subgingival
levels of Gram-negative anaerobic microorganisms occurs during
the second trimester of pregnancy [32,33]. The likely explanation
is that the local accumulation of active progesterone and oestrogen
may provide the essential nutrients that selectively enhance their
growth [34,35]. Androgen production is a major trait of PCOS
and essential for follicle development [36]. Although the overpro-
duction of luteinizing hormone is evident, the absence of the peak
level of the hormone results in higher levels of progesterone and
estrogen production [37]. Such hormonal changes in PCOS are
likely to influence the salivary levels of putative periodontal
pathogens, or their systemic antibody responses, particularly when
associated with gingival inflammation.
To our knowledge, this is the first study to investigate the
association between PCOS and oral microbiota in saliva and their
serum antibody responses, in regards to gingival inflammation.
The findings demonstrated that the levels of most of the studied
putative periodontal pathogens, except A. actinomycetemcomitans
and T. denticola, were elevated in women with PCOS and
gingivitis compared to the matched periodontally healthy controls.
PCOS appeared to have an enhancing effect on the levels of P.
gingivalis and F. nucleatum and their association with gingival
inflammation, hinting towards a microbial specificity.
Table 1. Age demographics and clinical periodontal measurements.
PCOS - health (n=45) PCOS - gingivitis (n =35) Health - health (n=25) Health - gingivitis (n = 20)
Age (Years) 25.0265.86 26.4065.77 25.8464.07 26.4065.42
PD (mm) 1.3260.39 1.9560.24**** 1.2660.45 1.9460.22****
PI (Score 0–3) 0.7560.34 2.1360.39**** 0.8260.46 2.0560.43********
BOP (%) 8.80610.73 73.45617.31**** 10.21613.82 68.52621.73****
****p,0.0001, PD = Probing pocket depth (mm), PI = Plaque Index, BOP = Bleeding on probing (%). Clinical diagnosis groups: PCOS with periodontal health (PCOS -
health); PCOS with gingivitis (PCOS - gingivitis); systemically healthy with periodontal health (Health - health); systemically healthy with gingivitis (Health - gingivitis).
Values are shown as mean 6 standard deviation.
doi:10.1371/journal.pone.0108074.t001
Table 2. Frequency of detection of different species per clinical group.
Species PCOS - health PCOS - gingivitis Health - health Health - gingivitis
P. gingivalis 45/45 (100%) 34/35 (97%) 25/25 (100%) 18/20 (90%)
T. denticola 32/45 (71%) 34/35 (97%) 18/25 (72%) 17/20 (85%)
T. forsythia 42/45 (93%) 35/35 (100%) 23/25 (92%) 19/20 (95%)
A. actinomycetemcomitans 44/45 (98%) 35/35 (100%) 25/25 (100%) 18/20 (90%)
P. intermedia 43/45 (96%) 33/35 (94%) 25/25 (100%) 20/20 (100%)
F. nucleatum 45/45 (100%) 35/35 (100%) 25/25 (100%) 19/20 (95%)
S. oralis 45/45 (100%) 35/35 (100%) 25/25 (100%) 20/20 (95%)
Clinical diagnosis groups: PCOS with periodontal health (PCOS - health); PCOS with gingivitis (PCOS - gingivitis); systemically healthy with periodontal health (Health -
health); systemically healthy with gingivitis (Health - gingivitis).
doi:10.1371/journal.pone.0108074.t002
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Figure 1. Levels of detection of different species in saliva. Levels of detection of different species in saliva from PCOS with periodontal health
(ph) (n = 45); PCOS with gingivitis (pg) (n = 35); systemically healthy with periodontal health (hh) (n = 25); systemically healthy with gingivitis (hg)
(n = 20). The individual values represent bacterial counts in saliva (A); Total bacterial counts (B); A. actinomycetemcomitans, (C); T. denticola, (D); P.
gingivalis, (E); F. nucleatum, (F); P. intermedia, (G); T. forsythia, and (H); S. oralis in both groups. The horizontal lines in the boxplots represent the
median values and the whiskers represent the 5–95 percentiles. Values below and above the whiskers are drawn as individual dots. *p,0.05, **p,
0.01, ***p,0.001.
doi:10.1371/journal.pone.0108074.g001
Polycystic Ovary Syndrome and Oral Microbiota
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Measurement of serum antibody levels provides information on
host reaction to the oral microbiota [20], as they may be associated
with the progression from periodontal health to disease [38], or
define disease-susceptible or disease-resistant individuals [39]. In
systemically healthy individuals there were no major differences in
serum antibody levels according to periodontal status, despite
differences in the subgingival microbiota [40] However the
systemic health status may alter the serum antibody responses to
periodontal pathogens, as demonstrated in patients with poor
glycaemic control [41]. To this extent, serum antibody levels to C.
Figure 2. Antibody levels of different species in serum. Antibody levels of different species in serum from PCOS with periodontal health (ph)
(n = 45); PCOS with gingivitis (pg) (n = 35); systemically healthy with periodontal health (hh) (n = 24); systemically healthy with gingivitis (hg) (n = 20).
The individual values represent antibody levels in serum (A); P. gingivalis, (B); T. denticola, (C); T. forsythia, (D); A. actinomycetemcomitans, (E); F.
nucleatum, (F); P. intermedia, and (G); S. oralis in both groups. The horizontal line indicates the study groups. The horizontal lines in the boxplots
represent the median values and the whiskers represent the 5–95 percentiles. Values below and above the whiskers are drawn as individual dots.
*p= 0.02, **p= 0.01.
doi:10.1371/journal.pone.0108074.g002
Polycystic Ovary Syndrome and Oral Microbiota
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rectus were elevated in type 2 diabetes, whereas antibody levels to
P. gingivalis were elevated in periodontitis, irrespective of diabetic
health status [42]. Recent evidence also shows that serum antibody
levels of A. actinomycetemcomitans, P. gingivalis and P. intermedia
are associated with an increased risk of coronary heart disease
[43]. In the present study, serum antibody levels to P. gingivalis,
P. intermedia and S. oralis were elevated in the presence of PCOS.
This may indicate that this endocrine disorder may affect the
antigenic susceptibility to these species. Although in systemic
health no positive correlation was found between gingival
inflammation (as evaluated by BOP scores) and serum antibody
levels to any of the studied species, in the presence of PCOS a
positive correlation was found only for P. gingivalis. Moreover,
salivary counts and serum antibody levels of P. gingivalis, as well
as F. nucleatum, strongly correlated with each other.
Serum antibody levels may provide insights for understanding
individual systemic host responses to periodontal microbiota,
although the particular associations are not well understood to
date. To this extent, a national US survey has shown that
demographic, behavioural, oral and general health-related char-
acteristics were strong determinants of systemic antibody responses
to periodontal bacteria [20,44]. In this regard, it is reasonable to
consider that PCOS may well be a modifier of periodontal health
status and systemic antibody responses in the female population.
In conclusion, PCOS may affect the composition of the oral
microflora and modify the systemic antibody responses to selective
members of this microbial community, with repercussions in
periodontal health. Among the studied taxa, the strongest effect
was exerted on P. gingivalis, as PCOS enhances its presence in
saliva and the serum antibody responses to it, particularly in the
presence of gingival inflammation. Hence, this study reveals that
the positive association between oral microbiota and gingival
inflammation is further potentiated by this endocrine disorder.
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